AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| ANZ | Ann: Guide to ANZ's Half Year 2018 Results | 23/04/18 | 0 | 20 | |||
|
|||||||
| ANZ | Ann: Notice Corporations Act Subsection 259C(2) | 23/04/18 | 0 | 9 | |||
|
|||||||
| ANZ | Ann: Change of Director's Interest Notice | 20/04/18 | 0 | 17 | |||
|
|||||||
| ANZ | Ann: Deputy Chief Executive Officer Graham Hodges to retire | 11/04/18 | 0 | 27 | |||
|
|||||||
| ANZ | Ann: Notice Corporations Act Subsection 259C(2) | 06/04/18 | 0 | 30 | |||
|
|||||||
| ANZ | Ann: Dividend/Distribution - ANZPF | 29/03/18 | 0 | 29 | |||
|
|||||||
| ANZ | Ann: Dividend/Distribution - ANZPE | 29/03/18 | 0 | 33 | |||
|
|||||||
| ANZ | Ann: Notification of cancellation of shares | 29/03/18 | 0 | 24 | |||
|
|||||||
See All Discussions
NZX News